STAG1_HUMAN - dbPTM
STAG1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID STAG1_HUMAN
UniProt AC Q8WVM7
Protein Name Cohesin subunit SA-1
Gene Name STAG1
Organism Homo sapiens (Human).
Sequence Length 1258
Subcellular Localization Nucleus. Chromosome. Chromosome, centromere. Associates with chromatin. Before prophase it is scattered along chromosome arms. During prophase, most of cohesin complexes dissociate from chromatin probably because of phosphorylation by PLK1, except at
Protein Description Component of cohesin complex, a complex required for the cohesion of sister chromatids after DNA replication. The cohesin complex apparently forms a large proteinaceous ring within which sister chromatids can be trapped. At anaphase, the complex is cleaved and dissociates from chromatin, allowing sister chromatids to segregate. The cohesin complex may also play a role in spindle pole assembly during mitosis..
Protein Sequence MITSELPVLQDSTNETTAHSDAGSELEETEVKGKRKRGRPGRPPSTNKKPRKSPGEKSRIEAGIRGAGRGRANGHPQQNGEGEPVTLFEVVKLGKSAMQSVVDDWIESYKQDRDIALLDLINFFIQCSGCRGTVRIEMFRNMQNAEIIRKMTEEFDEDSGDYPLTMPGPQWKKFRSNFCEFIGVLIRQCQYSIIYDEYMMDTVISLLTGLSDSQVRAFRHTSTLAAMKLMTALVNVALNLSIHQDNTQRQYEAERNKMIGKRANERLELLLQKRKELQENQDEIENMMNSIFKGIFVHRYRDAIAEIRAICIEEIGVWMKMYSDAFLNDSYLKYVGWTLHDRQGEVRLKCLKALQSLYTNRELFPKLELFTNRFKDRIVSMTLDKEYDVAVEAIRLVTLILHGSEEALSNEDCENVYHLVYSAHRPVAVAAGEFLHKKLFSRHDPQAEEALAKRRGRNSPNGNLIRMLVLFFLESELHEHAAYLVDSLWESSQELLKDWECMTELLLEEPVQGEEAMSDRQESALIELMVCTIRQAAEAHPPVGRGTGKRVLTAKERKTQIDDRNKLTEHFIITLPMLLSKYSADAEKVANLLQIPQYFDLEIYSTGRMEKHLDALLKQIKFVVEKHVESDVLEACSKTYSILCSEEYTIQNRVDIARSQLIDEFVDRFNHSVEDLLQEGEEADDDDIYNVLSTLKRLTSFHNAHDLTKWDLFGNCYRLLKTGIEHGAMPEQIVVQALQCSHYSILWQLVKITDGSPSKEDLLVLRKTVKSFLAVCQQCLSNVNTPVKEQAFMLLCDLLMIFSHQLMTGGREGLQPLVFNPDTGLQSELLSFVMDHVFIDQDEENQSMEGDEEDEANKIEALHKRRNLLAAFSKLIIYDIVDMHAAADIFKHYMKYYNDYGDIIKETLSKTRQIDKIQCAKTLILSLQQLFNELVQEQGPNLDRTSAHVSGIKELARRFALTFGLDQIKTREAVATLHKDGIEFAFKYQNQKGQEYPPPNLAFLEVLSEFSSKLLRQDKKTVHSYLEKFLTEQMMERREDVWLPLISYRNSLVTGGEDDRMSVNSGSSSSKTSSVRNKKGRPPLHKKRVEDESLDNTWLNRTDTMIQTPGPLPAPQLTSTVLRENSRPMGDQIQEPESEHGSEPDFLHNPQMQISWLGQPKLEDLNRKDRTGMNYMKVRTGVRHAVRGLMEEDAEPIFEDVMMSSRSQLEDMNEEFEDTMVIDLPPSRNRRERAELRPDFFDSAAIIEDDSGFGMPMF
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
3Phosphorylation-----MITSELPVLQ
-----CCCCCCCCEE
28.1830108239
4Phosphorylation----MITSELPVLQD
----CCCCCCCCEEC
42.6930108239
12PhosphorylationELPVLQDSTNETTAH
CCCCEECCCCCCCCC
21.8525159151
13PhosphorylationLPVLQDSTNETTAHS
CCCEECCCCCCCCCC
45.4225159151
16PhosphorylationLQDSTNETTAHSDAG
EECCCCCCCCCCCCC
31.2125159151
17PhosphorylationQDSTNETTAHSDAGS
ECCCCCCCCCCCCCC
19.0525159151
20PhosphorylationTNETTAHSDAGSELE
CCCCCCCCCCCCCCC
27.0525159151
24PhosphorylationTAHSDAGSELEETEV
CCCCCCCCCCCCCCC
40.5025159151
29PhosphorylationAGSELEETEVKGKRK
CCCCCCCCCCCCCCC
36.3824043423
45PhosphorylationGRPGRPPSTNKKPRK
CCCCCCCCCCCCCCC
47.5028348404
46PhosphorylationRPGRPPSTNKKPRKS
CCCCCCCCCCCCCCC
57.7522067460
57AcetylationPRKSPGEKSRIEAGI
CCCCCCCHHHHHHHC
51.4526051181
65MethylationSRIEAGIRGAGRGRA
HHHHHHCCCCCCCCC
28.17115917909
152PhosphorylationAEIIRKMTEEFDEDS
HHHHHHHHHCCCCCC
35.08-
159PhosphorylationTEEFDEDSGDYPLTM
HHCCCCCCCCCCCCC
31.36-
162PhosphorylationFDEDSGDYPLTMPGP
CCCCCCCCCCCCCCH
12.03-
165PhosphorylationDSGDYPLTMPGPQWK
CCCCCCCCCCCHHHH
19.47-
172AcetylationTMPGPQWKKFRSNFC
CCCCHHHHHHHHHHH
36.4726051181
273UbiquitinationRLELLLQKRKELQEN
HHHHHHHHHHHHHHC
66.4621890473
273UbiquitinationRLELLLQKRKELQEN
HHHHHHHHHHHHHHC
66.4621890473
290PhosphorylationEIENMMNSIFKGIFV
HHHHHHHHHHHHHHH
16.1124719451
333MethylationFLNDSYLKYVGWTLH
HCCHHHHHHHHEEEC
29.65-
356PhosphorylationKCLKALQSLYTNREL
HHHHHHHHHHHCCCH
24.9721406692
358PhosphorylationLKALQSLYTNRELFP
HHHHHHHHHCCCHHH
13.7621406692
359PhosphorylationKALQSLYTNRELFPK
HHHHHHHHCCCHHHH
32.8521406692
366UbiquitinationTNRELFPKLELFTNR
HCCCHHHHHHHHHHH
47.4621890473
366UbiquitinationTNRELFPKLELFTNR
HCCCHHHHHHHHHHH
47.4621890473
380PhosphorylationRFKDRIVSMTLDKEY
HHHHHHHHCCCCCCH
12.0430576142
382PhosphorylationKDRIVSMTLDKEYDV
HHHHHHCCCCCCHHH
25.0530576142
453AcetylationQAEEALAKRRGRNSP
HHHHHHHHHCCCCCC
43.4025953088
453UbiquitinationQAEEALAKRRGRNSP
HHHHHHHHHCCCCCC
43.40-
523PhosphorylationAMSDRQESALIELMV
HCCHHHHHHHHHHHH
21.7530631047
568PhosphorylationIDDRNKLTEHFIITL
CCCCCHHHHHHHHHH
29.0825159151
574PhosphorylationLTEHFIITLPMLLSK
HHHHHHHHHHHHHHH
21.7220068231
580PhosphorylationITLPMLLSKYSADAE
HHHHHHHHHCCCCHH
26.1120068231
618MethylationKHLDALLKQIKFVVE
HHHHHHHHHHHHHHH
51.32-
621AcetylationDALLKQIKFVVEKHV
HHHHHHHHHHHHHHC
29.6122649355
626AcetylationQIKFVVEKHVESDVL
HHHHHHHHHCCHHHH
41.1426051181
639PhosphorylationVLEACSKTYSILCSE
HHHHHHHHHHHHCCC
13.2528851738
640PhosphorylationLEACSKTYSILCSEE
HHHHHHHHHHHCCCC
9.4628851738
641PhosphorylationEACSKTYSILCSEEY
HHHHHHHHHHCCCCC
17.8328851738
645PhosphorylationKTYSILCSEEYTIQN
HHHHHHCCCCCCHHC
29.9828851738
648PhosphorylationSILCSEEYTIQNRVD
HHHCCCCCCHHCCHH
12.7028851738
689PhosphorylationEADDDDIYNVLSTLK
CCCHHHHHHHHHHHH
13.2518452278
694PhosphorylationDIYNVLSTLKRLTSF
HHHHHHHHHHHHHCC
31.9418452278
700O-linked_GlycosylationSTLKRLTSFHNAHDL
HHHHHHHCCCCHHCC
29.1530059200
753PhosphorylationLWQLVKITDGSPSKE
HHHHHCCCCCCCCHH
28.7023186163
756PhosphorylationLVKITDGSPSKEDLL
HHCCCCCCCCHHHHH
28.8929255136
758PhosphorylationKITDGSPSKEDLLVL
CCCCCCCCHHHHHHH
50.8329255136
759AcetylationITDGSPSKEDLLVLR
CCCCCCCHHHHHHHH
59.6426051181
759UbiquitinationITDGSPSKEDLLVLR
CCCCCCCHHHHHHHH
59.64-
781PhosphorylationAVCQQCLSNVNTPVK
HHHHHHHHCCCCCHH
46.49-
847PhosphorylationDQDEENQSMEGDEED
CCCHHCCCCCCCHHH
30.3126657352
864UbiquitinationNKIEALHKRRNLLAA
HHHHHHHHHHHHHHH
54.63-
893PhosphorylationAADIFKHYMKYYNDY
HHHHHHHHHHHHCHH
8.9022817900
896PhosphorylationIFKHYMKYYNDYGDI
HHHHHHHHHCHHHHH
7.3222817900
897PhosphorylationFKHYMKYYNDYGDII
HHHHHHHHCHHHHHH
8.9522817900
900PhosphorylationYMKYYNDYGDIIKET
HHHHHCHHHHHHHHH
17.0418083107
905UbiquitinationNDYGDIIKETLSKTR
CHHHHHHHHHHHHCC
45.01-
905AcetylationNDYGDIIKETLSKTR
CHHHHHHHHHHHHCC
45.0126051181
916UbiquitinationSKTRQIDKIQCAKTL
HHCCCCCHHHHHHHH
35.98-
962PhosphorylationLARRFALTFGLDQIK
HHHHHHHHHCCHHHH
16.5420068231
1021PhosphorylationLLRQDKKTVHSYLEK
HHHCCHHHHHHHHHH
29.2329449344
1024PhosphorylationQDKKTVHSYLEKFLT
CCHHHHHHHHHHHHH
27.3829449344
1025PhosphorylationDKKTVHSYLEKFLTE
CHHHHHHHHHHHHHH
12.1929449344
1031PhosphorylationSYLEKFLTEQMMERR
HHHHHHHHHHHHHHC
27.5724719451
1051PhosphorylationPLISYRNSLVTGGED
HHHEECCCCCCCCCC
18.4123927012
1054PhosphorylationSYRNSLVTGGEDDRM
EECCCCCCCCCCCCC
44.7729255136
1062PhosphorylationGGEDDRMSVNSGSSS
CCCCCCCCCCCCCCC
21.0223401153
1065PhosphorylationDDRMSVNSGSSSSKT
CCCCCCCCCCCCCCC
37.5923401153
1067PhosphorylationRMSVNSGSSSSKTSS
CCCCCCCCCCCCCCC
27.2029255136
1068PhosphorylationMSVNSGSSSSKTSSV
CCCCCCCCCCCCCCC
42.0023927012
1069PhosphorylationSVNSGSSSSKTSSVR
CCCCCCCCCCCCCCC
37.2423927012
1070PhosphorylationVNSGSSSSKTSSVRN
CCCCCCCCCCCCCCC
41.7323927012
1072PhosphorylationSGSSSSKTSSVRNKK
CCCCCCCCCCCCCCC
28.3420068231
1073PhosphorylationGSSSSKTSSVRNKKG
CCCCCCCCCCCCCCC
30.4920068231
1074PhosphorylationSSSSKTSSVRNKKGR
CCCCCCCCCCCCCCC
30.2620068231
1093PhosphorylationKKRVEDESLDNTWLN
CCCCCCCCCCCCCCC
54.0325159151
1097PhosphorylationEDESLDNTWLNRTDT
CCCCCCCCCCCCCCC
30.8823186163
1102PhosphorylationDNTWLNRTDTMIQTP
CCCCCCCCCCCCCCC
34.4527732954
1104PhosphorylationTWLNRTDTMIQTPGP
CCCCCCCCCCCCCCC
18.6327732954
1108PhosphorylationRTDTMIQTPGPLPAP
CCCCCCCCCCCCCCC
21.2027499020
1118PhosphorylationPLPAPQLTSTVLREN
CCCCCCHHHHHHHHC
19.6628122231
1119PhosphorylationLPAPQLTSTVLRENS
CCCCCHHHHHHHHCC
25.7222210691
1120PhosphorylationPAPQLTSTVLRENSR
CCCCHHHHHHHHCCC
20.5124719451
1126PhosphorylationSTVLRENSRPMGDQI
HHHHHHCCCCCCCCC
32.7726657352
1138PhosphorylationDQIQEPESEHGSEPD
CCCCCCCCCCCCCCC
45.6822115753
1138 (in isoform 2)Phosphorylation-45.6823663014
1142 (in isoform 2)Phosphorylation-48.1123663014
1142PhosphorylationEPESEHGSEPDFLHN
CCCCCCCCCCCCCCC
48.1122115753
1155PhosphorylationHNPQMQISWLGQPKL
CCCCCCEEECCCCCH
10.1921406692
1161SumoylationISWLGQPKLEDLNRK
EEECCCCCHHHCCCC
57.5328112733
1171PhosphorylationDLNRKDRTGMNYMKV
HCCCCCCCCCHHHHH
51.41-
1204PhosphorylationIFEDVMMSSRSQLED
HHHHHHHHCHHHHHH
12.4227732954
1205PhosphorylationFEDVMMSSRSQLEDM
HHHHHHHCHHHHHHC
20.3227732954
1251PhosphorylationAAIIEDDSGFGMPMF
CEEEECCCCCCCCCC
48.6329802988

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of STAG1_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of STAG1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of STAG1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
SMC1A_HUMANSMC1Aphysical
11076961
SMC3_HUMANSMC3physical
11076961
RAD21_HUMANRAD21physical
11076961
RAD21_HUMANRAD21physical
17113138
SMC1A_HUMANSMC1Aphysical
17113138
SMC3_HUMANSMC3physical
17113138
PDS5A_HUMANPDS5Aphysical
17113138
PDS5B_HUMANPDS5Bphysical
17113138
WFDC5_HUMANWFDC5physical
17112726
RAD21_HUMANRAD21physical
17112726
SMC1A_HUMANSMC1Aphysical
17112726
SMC3_HUMANSMC3physical
17112726
RAD21_HUMANRAD21physical
17962804
SMC3_HUMANSMC3physical
17962804
TERF1_HUMANTERF1physical
17962804
TINF2_HUMANTINF2physical
17962804
SMC1A_HUMANSMC1Aphysical
10931856
SMC3_HUMANSMC3physical
10931856
RAD21_HUMANRAD21physical
10931856
EXOS9_HUMANEXOSC9physical
26344197
RAD21_HUMANRAD21physical
26344197
SMC1A_HUMANSMC1Aphysical
26344197
SMC1B_HUMANSMC1Bphysical
26344197
WAPL_HUMANWAPALphysical
17113138

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of STAG1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-621, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-24, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1062; SER-1065 ANDSER-1067, AND MASS SPECTROMETRY.

TOP